Melissa Gregory
Pediatric Nephrology Detroit, MI Medical Doctor
NPI 1386604460 CMS profile 1171264
3901 Beaubien, Children's Hospital Of Mi, Detroit, MI 48201
General payments
$221
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$10,223
Through program year 2025, Melissa Gregory of Detroit, MI is reported in the CMS Open Payments database as having received $221 across 7 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,223 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 47th percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $93 | 4 | |
| 2022 | General | $24 | 1 | |
| 2019 | General | $104 | 2 |
Beside peers
- Melissa Gregory
- Pediatric Nephrology median
- Middle half of Pediatric Nephrology
- National median
In program year 2025, general payments to Melissa Gregory were reported at $93. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.
Show as a table
| Year | Melissa Gregory | Pediatric Nephrology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $104 | $123 | $48–$353 | $163 |
| 2020 | $0 | $146 | $24–$2,251 | $114 |
| 2021 | $0 | $138 | $26–$1,371 | $132 |
| 2022 | $24 | $93 | $25–$427 | $149 |
| 2023 | $0 | $105 | $30–$375 | $160 |
| 2024 | $0 | $123 | $40–$481 | $164 |
| 2025 | $93 | $131 | $47–$474 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 9 billing codesPaid by Medicare
$4,799
Medicare patients
11
Services billed
57
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Ischemic heart disease | 0% | |
| Atrial fibrillation | 0% | |
| COPD | 0% | |
| Cancer | 0% | |
| Depression | 0% | |
| Arthritis | 0% | |
| Osteoporosis | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Nephrology in Michigan
Tej Mattoo
Pediatric Nephrology · Detroit, MI
Alejandro Quiroga Chand
Pediatric Nephrology · Grand Rapids, MI
David Kershaw
Pediatric Nephrology · Ann Arbor, MI
Jens Goebel
Pediatric Nephrology · Grand Rapids, MI
Gaurav Kapur
Pediatric Nephrology · Detroit, MI
Jason Thomas
Pediatric Nephrology · Grand Rapids, MI
Related records
Pediatric Nephrology in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Nephrology
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.